Small-molecule inhibitors of Nucleotide Excision Repair

Tech ID:
HSC-1612

Small molecule inhibitors of Nucleotide Excision Repair

 

XPF/ERCC1 is a structure-specific nuclease whose activity is essential for nucleotide excision repair (NER),

interstrand crosslink repair (ICL) and other pathways of DNA damage repair. In NER, the recruitment and

activation of XPF/ERCC1 depend on the interaction with XPA, another essential component of the NER preincision

complex. Here we report series of small-molecule inhibitors of interactions between XPA and ERCC1

identified by high-throughput screening (HTS) of compound libraries. 2,3,4,5-tetrahydro-1,5-dioxopyrrolo[1,2-

a]quinazoline derivatives bind in the XPA-binding pocket of the ERCC1 central domain and act as competitive

inhibitors of XPA-ERCC1 interactions. These compounds inhibit NER in cell extracts and sensitize A549

human lung cancer cells to UV irradiation. Structures of protein-inhibitor complexes determined by X-ray

crystallography identify key intermolecular contacts and suggest strategies for compound optimization. We also

report preliminary investigations of structure-activity relationships in this compound family. Our studies

establish feasibility of NER inhibition by drug-like low-molecular-weight compounds that bind in the XPA-binding

pocket of ERCC1.

Category(s):
Oncology
Small Molecule
For information contact:
Daniel Rafferty
Business Development Manager
raffertyde@uthscsa.edu
(210) 562-4038
Inventors:
Dmitri Ivanov
Patent Information:
Keywords: